LayerRx Mapping ID
268
Slot System
Featured Buckets
Featured Buckets Admin

Maximizing antihypertensive management in the elderly

Article Type
Changed
Tue, 02/12/2019 - 10:04
Display Headline
Maximizing antihypertensive management in the elderly
Article PDF
Author and Disclosure Information

Norman M. Kaplan, MD
Department of Internal Medicine, University of Texas Southwestern Medical School, Dallas; Dallas Heart Disease Prevention Project

Address: Norman M. Kaplan, MD, Department of Internal Medicine, University of Texas Southwestern Medical School, 5323 Harry Hines Drive, CS8.102, Dallas, TX 75235-8899

Issue
Cleveland Clinic Journal of Medicine - 67(8)
Publications
Topics
Page Number
551-553
Sections
Author and Disclosure Information

Norman M. Kaplan, MD
Department of Internal Medicine, University of Texas Southwestern Medical School, Dallas; Dallas Heart Disease Prevention Project

Address: Norman M. Kaplan, MD, Department of Internal Medicine, University of Texas Southwestern Medical School, 5323 Harry Hines Drive, CS8.102, Dallas, TX 75235-8899

Author and Disclosure Information

Norman M. Kaplan, MD
Department of Internal Medicine, University of Texas Southwestern Medical School, Dallas; Dallas Heart Disease Prevention Project

Address: Norman M. Kaplan, MD, Department of Internal Medicine, University of Texas Southwestern Medical School, 5323 Harry Hines Drive, CS8.102, Dallas, TX 75235-8899

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 67(8)
Issue
Cleveland Clinic Journal of Medicine - 67(8)
Page Number
551-553
Page Number
551-553
Publications
Publications
Topics
Article Type
Display Headline
Maximizing antihypertensive management in the elderly
Display Headline
Maximizing antihypertensive management in the elderly
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

What is the appropriate initial dose of corticosteroids to treat giant cell arteritis?

Article Type
Changed
Tue, 02/12/2019 - 09:55
Display Headline
What is the appropriate initial dose of corticosteroids to treat giant cell arteritis?
Article PDF
Author and Disclosure Information

William S. Wilke, MD
Department of Rheumatic and Immunologic Disease, Cleveland Clinic

Address: William S. Wilke, MD, Department of Rheumatic and Immunologic Disease, A51, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Issue
Cleveland Clinic Journal of Medicine - 67(8)
Publications
Topics
Page Number
546-548
Sections
Author and Disclosure Information

William S. Wilke, MD
Department of Rheumatic and Immunologic Disease, Cleveland Clinic

Address: William S. Wilke, MD, Department of Rheumatic and Immunologic Disease, A51, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Author and Disclosure Information

William S. Wilke, MD
Department of Rheumatic and Immunologic Disease, Cleveland Clinic

Address: William S. Wilke, MD, Department of Rheumatic and Immunologic Disease, A51, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 67(8)
Issue
Cleveland Clinic Journal of Medicine - 67(8)
Page Number
546-548
Page Number
546-548
Publications
Publications
Topics
Article Type
Display Headline
What is the appropriate initial dose of corticosteroids to treat giant cell arteritis?
Display Headline
What is the appropriate initial dose of corticosteroids to treat giant cell arteritis?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Preventive medicine and screening in the elderly: Working guidelines

Article Type
Changed
Tue, 02/12/2019 - 12:09
Display Headline
Preventive medicine and screening in the elderly: Working guidelines
Article PDF
Author and Disclosure Information

Todd H. Goldberg, MD
Assistant Professor of Medicine, Temple University School of Medicine; Division of Geriatric Medicine, Albert Einstein Medical Center, Philadelphia

Address: Todd H. Goldberg, MD, Division of Geriatric Medicine, Albert Einstein Medical Center, 5501 Old York Road, Philadelphia, PA 19141

Issue
Cleveland Clinic Journal of Medicine - 67(7)
Publications
Topics
Page Number
521-530
Sections
Author and Disclosure Information

Todd H. Goldberg, MD
Assistant Professor of Medicine, Temple University School of Medicine; Division of Geriatric Medicine, Albert Einstein Medical Center, Philadelphia

Address: Todd H. Goldberg, MD, Division of Geriatric Medicine, Albert Einstein Medical Center, 5501 Old York Road, Philadelphia, PA 19141

Author and Disclosure Information

Todd H. Goldberg, MD
Assistant Professor of Medicine, Temple University School of Medicine; Division of Geriatric Medicine, Albert Einstein Medical Center, Philadelphia

Address: Todd H. Goldberg, MD, Division of Geriatric Medicine, Albert Einstein Medical Center, 5501 Old York Road, Philadelphia, PA 19141

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 67(7)
Issue
Cleveland Clinic Journal of Medicine - 67(7)
Page Number
521-530
Page Number
521-530
Publications
Publications
Topics
Article Type
Display Headline
Preventive medicine and screening in the elderly: Working guidelines
Display Headline
Preventive medicine and screening in the elderly: Working guidelines
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Lowering LDL in patients with heart disease: How aggressive should you be?

Article Type
Changed
Tue, 02/12/2019 - 11:56
Display Headline
Lowering LDL in patients with heart disease: How aggressive should you be?
Article PDF
Author and Disclosure Information

Thomas A. Pearson, MD, PhD
Chairman, Department of Community and Preventive Medicine and Albert D. Kaiser Professor, University of Rochester Medical Center, New York

Fredric J. Pashkow, MD
Medical director, Heart Institute, Queen’s Medical Center, Honolulu, Hawaii; Adjunct staff, Cleveland Clinic

Addresses: Thomas A. Pearson, MD, PhD, Department of Community and Preventive Medicine, PO Box 644, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642; Fredric J. Pashkow, MD, Medical Director, Heart Institute, The Queen's Medical Center, 1301 Punchbowl St., Honolulu, HI 96813

Dr. Pearson has indicated that he has received grant or research support and serves as a consultant and a member of the speakers' bureau for several companies that manufacture lipid-lowering drugs.

Dr. Pashkow has also indicated that he serves on the speakers' bureau of several of these companies.

Issue
Cleveland Clinic Journal of Medicine - 67(7)
Publications
Topics
Page Number
489-490, 493-494, 496
Sections
Author and Disclosure Information

Thomas A. Pearson, MD, PhD
Chairman, Department of Community and Preventive Medicine and Albert D. Kaiser Professor, University of Rochester Medical Center, New York

Fredric J. Pashkow, MD
Medical director, Heart Institute, Queen’s Medical Center, Honolulu, Hawaii; Adjunct staff, Cleveland Clinic

Addresses: Thomas A. Pearson, MD, PhD, Department of Community and Preventive Medicine, PO Box 644, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642; Fredric J. Pashkow, MD, Medical Director, Heart Institute, The Queen's Medical Center, 1301 Punchbowl St., Honolulu, HI 96813

Dr. Pearson has indicated that he has received grant or research support and serves as a consultant and a member of the speakers' bureau for several companies that manufacture lipid-lowering drugs.

Dr. Pashkow has also indicated that he serves on the speakers' bureau of several of these companies.

Author and Disclosure Information

Thomas A. Pearson, MD, PhD
Chairman, Department of Community and Preventive Medicine and Albert D. Kaiser Professor, University of Rochester Medical Center, New York

Fredric J. Pashkow, MD
Medical director, Heart Institute, Queen’s Medical Center, Honolulu, Hawaii; Adjunct staff, Cleveland Clinic

Addresses: Thomas A. Pearson, MD, PhD, Department of Community and Preventive Medicine, PO Box 644, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642; Fredric J. Pashkow, MD, Medical Director, Heart Institute, The Queen's Medical Center, 1301 Punchbowl St., Honolulu, HI 96813

Dr. Pearson has indicated that he has received grant or research support and serves as a consultant and a member of the speakers' bureau for several companies that manufacture lipid-lowering drugs.

Dr. Pashkow has also indicated that he serves on the speakers' bureau of several of these companies.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 67(7)
Issue
Cleveland Clinic Journal of Medicine - 67(7)
Page Number
489-490, 493-494, 496
Page Number
489-490, 493-494, 496
Publications
Publications
Topics
Article Type
Display Headline
Lowering LDL in patients with heart disease: How aggressive should you be?
Display Headline
Lowering LDL in patients with heart disease: How aggressive should you be?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Treatment strategies for hepatitis C: Making the best of limited options

Article Type
Changed
Tue, 02/12/2019 - 11:49
Display Headline
Treatment strategies for hepatitis C: Making the best of limited options
Article PDF
Author and Disclosure Information

John G. McHutchison, MD
Director, Liver Transplantation Program; Division of Gastroenterology/Hepatology, Scripps Clinic and Research Foundation; La Jolla, Calif

Zobair Younossi, MD, MPH
Section of Hepatology, Department of Gastroenterology, Cleveland Clinic

Address: Zobair Younossi, MD, Department of Gastroenterology, S40, Cleveland Clinic, 9500
Euclid Avenue, Cleveland, OH 44195

Dr. McHutchison receives grant or research support from the Schering-Plough, Amgen, Roche, and Gilead companies, has served as a consultant for Schering-Plough and Roche, and has served on speakers' bureaus for Schering-Plough, Roche, and Amgen.

Dr. Younossi receives research support from Schering-Plough, Roche, and Interferon Sciences.

Issue
Cleveland Clinic Journal of Medicine - 67(7)
Publications
Topics
Page Number
476-480
Sections
Author and Disclosure Information

John G. McHutchison, MD
Director, Liver Transplantation Program; Division of Gastroenterology/Hepatology, Scripps Clinic and Research Foundation; La Jolla, Calif

Zobair Younossi, MD, MPH
Section of Hepatology, Department of Gastroenterology, Cleveland Clinic

Address: Zobair Younossi, MD, Department of Gastroenterology, S40, Cleveland Clinic, 9500
Euclid Avenue, Cleveland, OH 44195

Dr. McHutchison receives grant or research support from the Schering-Plough, Amgen, Roche, and Gilead companies, has served as a consultant for Schering-Plough and Roche, and has served on speakers' bureaus for Schering-Plough, Roche, and Amgen.

Dr. Younossi receives research support from Schering-Plough, Roche, and Interferon Sciences.

Author and Disclosure Information

John G. McHutchison, MD
Director, Liver Transplantation Program; Division of Gastroenterology/Hepatology, Scripps Clinic and Research Foundation; La Jolla, Calif

Zobair Younossi, MD, MPH
Section of Hepatology, Department of Gastroenterology, Cleveland Clinic

Address: Zobair Younossi, MD, Department of Gastroenterology, S40, Cleveland Clinic, 9500
Euclid Avenue, Cleveland, OH 44195

Dr. McHutchison receives grant or research support from the Schering-Plough, Amgen, Roche, and Gilead companies, has served as a consultant for Schering-Plough and Roche, and has served on speakers' bureaus for Schering-Plough, Roche, and Amgen.

Dr. Younossi receives research support from Schering-Plough, Roche, and Interferon Sciences.

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 67(7)
Issue
Cleveland Clinic Journal of Medicine - 67(7)
Page Number
476-480
Page Number
476-480
Publications
Publications
Topics
Article Type
Display Headline
Treatment strategies for hepatitis C: Making the best of limited options
Display Headline
Treatment strategies for hepatitis C: Making the best of limited options
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Preventing prescription drug abuse

Article Type
Changed
Mon, 02/11/2019 - 14:55
Display Headline
Preventing prescription drug abuse
Article PDF
Author and Disclosure Information

J.H. Isaacson, MD
Department of General Internal Medicine, Cleveland Clinic

 

Issue
Cleveland Clinic Journal of Medicine - 67(7)
Publications
Topics
Page Number
473-475
Sections
Author and Disclosure Information

J.H. Isaacson, MD
Department of General Internal Medicine, Cleveland Clinic

 

Author and Disclosure Information

J.H. Isaacson, MD
Department of General Internal Medicine, Cleveland Clinic

 

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 67(7)
Issue
Cleveland Clinic Journal of Medicine - 67(7)
Page Number
473-475
Page Number
473-475
Publications
Publications
Topics
Article Type
Display Headline
Preventing prescription drug abuse
Display Headline
Preventing prescription drug abuse
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Cisapride: Limited access and alternatives

Article Type
Changed
Tue, 02/12/2019 - 11:45
Display Headline
Cisapride: Limited access and alternatives
Article PDF
Author and Disclosure Information

Joel E. Richter, MD
Chairman, Department of Gastroenterology, Cleveland Clinic

Address: Joel E. Richter, MD, Department of Gastroenterology, S40, Cleveland Clinic, 9500
Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Richter discusses off-label use of medications.

Issue
Cleveland Clinic Journal of Medicine - 67(7)
Publications
Topics
Page Number
471-472
Sections
Author and Disclosure Information

Joel E. Richter, MD
Chairman, Department of Gastroenterology, Cleveland Clinic

Address: Joel E. Richter, MD, Department of Gastroenterology, S40, Cleveland Clinic, 9500
Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Richter discusses off-label use of medications.

Author and Disclosure Information

Joel E. Richter, MD
Chairman, Department of Gastroenterology, Cleveland Clinic

Address: Joel E. Richter, MD, Department of Gastroenterology, S40, Cleveland Clinic, 9500
Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Richter discusses off-label use of medications.

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 67(7)
Issue
Cleveland Clinic Journal of Medicine - 67(7)
Page Number
471-472
Page Number
471-472
Publications
Publications
Topics
Article Type
Display Headline
Cisapride: Limited access and alternatives
Display Headline
Cisapride: Limited access and alternatives
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

When should asymptomatic bacteriuria in the elderly be treated?

Article Type
Changed
Mon, 02/11/2019 - 12:57
Display Headline
When should asymptomatic bacteriuria in the elderly be treated?
Article PDF
Author and Disclosure Information

Thomas F. Keys, MD
Department of Infectious Disease, Cleveland Clinic

Address: Thomas F. Keys, MD, Department of Infectious Disease, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Issue
Cleveland Clinic Journal of Medicine - 67(7)
Publications
Topics
Page Number
466-467
Sections
Author and Disclosure Information

Thomas F. Keys, MD
Department of Infectious Disease, Cleveland Clinic

Address: Thomas F. Keys, MD, Department of Infectious Disease, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Author and Disclosure Information

Thomas F. Keys, MD
Department of Infectious Disease, Cleveland Clinic

Address: Thomas F. Keys, MD, Department of Infectious Disease, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 67(7)
Issue
Cleveland Clinic Journal of Medicine - 67(7)
Page Number
466-467
Page Number
466-467
Publications
Publications
Topics
Article Type
Display Headline
When should asymptomatic bacteriuria in the elderly be treated?
Display Headline
When should asymptomatic bacteriuria in the elderly be treated?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Drug-related topics selected for relevance to patient care

Article Type
Changed
Tue, 02/12/2019 - 11:31
Display Headline
Drug-related topics selected for relevance to patient care
Article PDF
Author and Disclosure Information

John D. Clough, MD
Editor in Chief

Issue
Cleveland Clinic Journal of Medicine - 67(7)
Publications
Topics
Page Number
464
Sections
Author and Disclosure Information

John D. Clough, MD
Editor in Chief

Author and Disclosure Information

John D. Clough, MD
Editor in Chief

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 67(7)
Issue
Cleveland Clinic Journal of Medicine - 67(7)
Page Number
464
Page Number
464
Publications
Publications
Topics
Article Type
Display Headline
Drug-related topics selected for relevance to patient care
Display Headline
Drug-related topics selected for relevance to patient care
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

The HOPE study

Article Type
Changed
Tue, 05/03/2022 - 16:11
Display Headline
The HOPE study
Article PDF
Author and Disclosure Information

Raed Bargout, MD
Oak Park, IL

Issue
Cleveland Clinic Journal of Medicine - 67(6)
Publications
Topics
Page Number
452
Sections
Author and Disclosure Information

Raed Bargout, MD
Oak Park, IL

Author and Disclosure Information

Raed Bargout, MD
Oak Park, IL

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 67(6)
Issue
Cleveland Clinic Journal of Medicine - 67(6)
Page Number
452
Page Number
452
Publications
Publications
Topics
Article Type
Display Headline
The HOPE study
Display Headline
The HOPE study
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media